Hutchinson-Gilford progeria syndrome: Rejuvenating old drugs to fight accelerated ageing

 

What if the next generation of successful treatments was hidden in the current pharmacopoeia?

Identifying new indications for existing drugs, also called the drug repurposing or drug rediscovery process, is a highly efficient and low-cost strategy. First reported almost a century ago, drug repurposing has emerged as a valuable therapeutic option for diseases that do not have specific treatments and rare diseases, in particular.

This review focuses on Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that induces accelerated and precocious aging, for which drug repurposing has led to the discovery of several potential treatments over the past decade.

 

 

Authors :
Solenn M Guilbert, Déborah Cardoso, Nicolas Lévy, Antoine Muchir et Xavier Nissan

 

DOI (link) : 10.1016/j.ymeth.2020.04.005